# FDA Inspection 1169930 - Octapharma Plasma, Inc. - May 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/c15be999-2fa1-4bc9-ad69-8975b3445a02
Source feed: FDA_Inspections

> FDA Inspection 1169930 for Octapharma Plasma, Inc. on May 13, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169930
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2022-05-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169930 - 2022-05-13](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/3902ac31-882e-48f1-b3b9-b3751169d19e)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/59ee02a0-07f0-4eec-8a38-a86383bf3f74

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d